Detalhe da pesquisa
1.
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Jpn J Clin Oncol
; 54(2): 153-159, 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37986553
2.
Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.
Jpn J Clin Oncol
; 53(7): 595-603, 2023 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37017320
3.
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
Jpn J Clin Oncol
; 52(1): 29-38, 2022 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34739075
4.
Impact of the Clinical Trials Act on Noncommercial Clinical Research in Japan: An Interrupted Time-series Analysis.
J Epidemiol
; 32(1): 27-33, 2022 01 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34690242
5.
[Acute myeloid leukemia harboring NUP98::DDX10].
Rinsho Ketsueki
; 63(10): 1397-1401, 2022.
Artigo
em Japonês
| MEDLINE | ID: mdl-36351646
6.
Venetoclax plus low-dose cytarabine in Japanese patients with untreated acute myeloid leukaemia ineligible for intensive chemotherapy.
Jpn J Clin Oncol
; 51(9): 1372-1382, 2021 Aug 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34322703
7.
[Acquired platelet dysfunction with severe bleeding tendency in triple-negative myelofibrosis].
Rinsho Ketsueki
; 62(9): 1406-1411, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34615801
8.
Silent NK/T cell reactions to dasatinib during sustained deep molecular response before cessation are associated with longer treatment-free remission.
Cancer Sci
; 111(8): 2923-2934, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32614159
9.
Correction to: Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.
Int J Clin Oncol
; 25(4): 782-783, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907718
10.
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever.
Mycoses
; 63(8): 794-801, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32391919
11.
Efficacy and Safety of a Weekly Cyclophosphamide-Bortezomib-Dexamethasone Regimen as Induction Therapy Prior to Autologous Stem Cell Transplantation in Japanese Patients with Newly Diagnosed Multiple Myeloma: A Phase 2 Multicenter Trial.
Acta Haematol
; 141(2): 111-118, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30726834
12.
Impact of oral voriconazole during chemotherapy for acute myeloid leukemia and myelodysplastic syndrome: a Japanese nationwide retrospective cohort study.
Int J Clin Oncol
; 24(11): 1449-1458, 2019 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300904
13.
Feasibility of the imatinib stop study in the Japanese clinical setting: delightedly overcome CML expert stop TKI trial (DOMEST Trial).
Int J Clin Oncol
; 24(4): 445-453, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421023
14.
[Successful Treatment of T-Cell Prolymphocytic Leukemia with Alemtuzumab].
Gan To Kagaku Ryoho
; 46(5): 913-915, 2019 May.
Artigo
em Japonês
| MEDLINE | ID: mdl-31189814
15.
Dasatinib cessation after deep molecular response exceeding 2 years and natural killer cell transition during dasatinib consolidation.
Cancer Sci
; 109(1): 182-192, 2018 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-29058817
16.
Dasatinib rapidly induces deep molecular response in chronic-phase chronic myeloid leukemia patients who achieved major molecular response with detectable levels of BCR-ABL1 transcripts by imatinib therapy.
Int J Clin Oncol
; 22(5): 972-979, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28550414
17.
Haploidentical transplantation using post-transplant high-dose cyclophosphamide for adult T-cell lymphoma after mogamulizumab treatment.
Rinsho Ketsueki
; 58(5): 449-454, 2017.
Artigo
em Japonês
| MEDLINE | ID: mdl-28592758
18.
Shorter halving time of BCR-ABL1 transcripts is a novel predictor for achievement of molecular responses in newly diagnosed chronic-phase chronic myeloid leukemia treated with dasatinib: Results of the D-first study of Kanto CML study group.
Am J Hematol
; 90(4): 282-7, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25530131
19.
Early cytotoxic lymphocyte expansion contributes to a deep molecular response to dasatinib in patients with newly diagnosed chronic myeloid leukemia in the chronic phase: results of the D-first study.
Am J Hematol
; 90(9): 819-24, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26103598
20.
Measurement of Proteasome Activity in Peripheral Blood Mononuclear Cells as an Indicator of Susceptibility to Bortezomib-Induced Severe Neurological Adverse Events in Patients with Multiple Myeloma.
Acta Haematol
; 134(1): 25-31, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25871926